These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11691515)

  • 1. Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibition.
    Labinjoh C; Newby DE; Pellegrini MP; Johnston NR; Boon NA; Webb DJ
    J Am Coll Cardiol; 2001 Nov; 38(5):1402-8. PubMed ID: 11691515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in man.
    Labinjoh C; Newby DE; Dawson P; Johnston NR; Ludlam CA; Boon NA; Webb DJ
    Cardiovasc Res; 2000 Sep; 47(4):707-14. PubMed ID: 10974219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute systemic inflammation enhances endothelium-dependent tissue plasminogen activator release in men.
    Chia S; Ludlam CA; Fox KA; Newby DE
    J Am Coll Cardiol; 2003 Jan; 41(2):333-9. PubMed ID: 12535831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin C has no effect on endothelium-dependent vasomotion and acute endogenous fibrinolysis in healthy smokers.
    Pellegrini MP; Newby DE; Johnston NR; Maxwell S; Webb DJ
    J Cardiovasc Pharmacol; 2004 Jul; 44(1):117-24. PubMed ID: 15175566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked bradykinin-induced tissue plasminogen activator release in patients with heart failure maintained on long-term angiotensin-converting enzyme inhibitor therapy.
    Witherow FN; Dawson P; Ludlam CA; Fox KA; Newby DE
    J Am Coll Cardiol; 2002 Sep; 40(5):961-6. PubMed ID: 12225723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term effects of transdermal nicotine on acute tissue plasminogen activator release in vivo in man.
    Pellegrini MP; Newby DE; Maxwell S; Webb DJ
    Cardiovasc Res; 2001 Nov; 52(2):321-7. PubMed ID: 11684081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin.
    Pretorius M; Rosenbaum D; Vaughan DE; Brown NJ
    Circulation; 2003 Feb; 107(4):579-85. PubMed ID: 12566370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: effects of angiotensin-converting enzyme inhibitors.
    Minai K; Matsumoto T; Horie H; Ohira N; Takashima H; Yokohama H; Kinoshita M
    J Am Coll Cardiol; 2001 May; 37(6):1565-70. PubMed ID: 11345366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.
    Brown NJ; Agirbasli M; Vaughan DE
    Hypertension; 1999 Aug; 34(2):285-90. PubMed ID: 10454455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature.
    Stein CM; Brown N; Vaughan DE; Lang CC; Wood AJ
    J Am Coll Cardiol; 1998 Jul; 32(1):117-22. PubMed ID: 9669258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vivo model for the assessment of acute fibrinolytic capacity of the endothelium.
    Newby DE; Wright RA; Ludlam CA; Fox KA; Boon NA; Webb DJ
    Thromb Haemost; 1997 Oct; 78(4):1242-8. PubMed ID: 9364992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acute methionine loading and vitamin C on endogenous fibrinolysis, endothelium-dependent vasomotion and platelet aggregation.
    Labinjoh C; Newby DE; Wilkinson IB; Megson IL; MacCallum H; Melville V; Boon NA; Webb DJ
    Clin Sci (Lond); 2001 Feb; 100(2):127-35. PubMed ID: 11171280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
    Cruden NL; Tse GH; Fox KA; Ludlam CA; Megson I; Newby DE
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):772-7. PubMed ID: 15681300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking impairs bradykinin-stimulated t-PA release.
    Pretorius M; Rosenbaum DA; Lefebvre J; Vaughan DE; Brown NJ
    Hypertension; 2002 Mar; 39(3):767-71. PubMed ID: 11897760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercholesterolaemia and lipid lowering treatment do not affect the acute endogenous fibrinolytic capacity in vivo.
    Newby DE; Witherow FN; Wright RA; Bloomfield P; Ludlam CA; Boon NA; Fox KA; Webb DJ
    Heart; 2002 Jan; 87(1):48-53. PubMed ID: 11751664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition.
    Van Guilder GP; Pretorius M; Luther JM; Byrd JB; Hill K; Gainer JV; Brown NJ
    Hypertension; 2008 Feb; 51(2):454-9. PubMed ID: 18180402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on postprandial endothelial function.
    Wilmink HW; Banga JD; Hijmering M; Erkelens WD; Stroes ES; Rabelink TJ
    J Am Coll Cardiol; 1999 Jul; 34(1):140-5. PubMed ID: 10400003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutral endopeptidase inhibition augments vascular actions of bradykinin in patients treated with angiotensin-converting enzyme inhibition.
    Cruden NL; Fox KA; Ludlam CA; Johnston NR; Newby DE
    Hypertension; 2004 Dec; 44(6):913-8. PubMed ID: 15492133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
    Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE
    J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bradykinin stimulates tissue plasminogen activator release in human vasculature.
    Brown NJ; Gainer JV; Stein CM; Vaughan DE
    Hypertension; 1999 Jun; 33(6):1431-5. PubMed ID: 10373228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.